US Stock MarketDetailed Quotes

COGT Cogent Biosciences

Watchlist
  • 7.840
  • +0.040+0.51%
Close Dec 20 16:00 ET
  • 7.840
  • 0.0000.00%
Post 17:22 ET
866.02MMarket Cap-3.16P/E (TTM)

Cogent Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
26.58%75.41M
36.75%64.39M
44.33%62.4M
40.78%208.13M
33.11%58.23M
61.81%59.58M
31.32%47.09M
37.62%43.24M
95.68%147.84M
70.61%43.75M
Selling and administrative expenses
24.83%11.8M
22.88%10.09M
34.73%9.7M
31.14%34.38M
35.78%9.51M
37.30%9.45M
28.83%8.21M
21.03%7.2M
33.48%26.21M
36.62%7M
-General and administrative expense
24.83%11.8M
22.88%10.09M
34.73%9.7M
31.14%34.38M
35.78%9.51M
37.30%9.45M
28.83%8.21M
21.03%7.2M
33.48%26.21M
36.62%7M
Research and development costs
26.91%63.61M
39.68%54.29M
46.25%52.71M
42.86%173.76M
32.60%48.72M
67.45%50.13M
31.86%38.87M
41.49%36.04M
117.53%121.63M
79.11%36.74M
Operating profit
-26.58%-75.41M
-36.75%-64.39M
-44.33%-62.4M
-40.78%-208.13M
-33.11%-58.23M
-61.81%-59.58M
-31.32%-47.09M
-37.62%-43.24M
-95.68%-147.84M
-70.61%-43.75M
Net non-operating interest income expense
13.84%4.78M
96.75%5.39M
78.88%4.06M
227.83%13.08M
83.41%3.87M
179.87%4.2M
907.72%2.74M
2,019.63%2.27M
754.18%3.99M
1,871.96%2.11M
Non-operating interest income
13.84%4.78M
96.75%5.39M
78.88%4.06M
227.83%13.08M
83.41%3.87M
179.87%4.2M
907.72%2.74M
2,019.63%2.27M
754.18%3.99M
1,871.96%2.11M
Other net income (expense)
1K
-83.58%44K
-100.04%-1K
-26.77%2.64M
-100.35%-7K
-59.15%268K
251.85%2.38M
28.39%3.61M
224.80%2.02M
Other non- operating income (expenses)
--1K
-83.58%44K
-100.04%-1K
-26.77%2.64M
-100.35%-7K
----
-59.15%268K
251.85%2.38M
28.39%3.61M
224.80%2.02M
Income before tax
-27.54%-70.63M
-33.75%-58.95M
-51.21%-58.35M
-37.20%-192.41M
-37.22%-54.37M
-57.95%-55.38M
-26.19%-44.08M
-25.96%-38.59M
-94.04%-140.24M
-59.03%-39.62M
Income tax
Net income
-27.54%-70.63M
-33.75%-58.95M
-51.21%-58.35M
-37.20%-192.41M
-37.22%-54.37M
-57.95%-55.38M
-26.19%-44.08M
-25.96%-38.59M
-94.04%-140.24M
-59.03%-39.62M
Net income continuous Operations
-27.54%-70.63M
-33.75%-58.95M
-51.21%-58.35M
-37.20%-192.41M
-37.22%-54.37M
-57.95%-55.38M
-26.19%-44.08M
-25.96%-38.59M
-94.04%-140.24M
-59.03%-39.62M
Minority interest income
Net income attributable to the parent company
-27.54%-70.63M
-33.75%-58.95M
-51.21%-58.35M
-37.20%-192.41M
-37.22%-54.37M
-57.95%-55.38M
-26.19%-44.08M
-25.96%-38.59M
-94.04%-140.24M
-59.03%-39.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-27.54%-70.63M
-33.75%-58.95M
-51.21%-58.35M
-37.20%-192.41M
-37.22%-54.37M
-57.95%-55.38M
-26.19%-44.08M
-25.96%-38.59M
-94.04%-140.24M
-59.03%-39.62M
Basic earnings per share
0.00%-0.64
0.00%-0.59
-12.73%-0.62
-1.26%-2.42
-12.50%-0.63
-28.00%-0.64
16.90%-0.59
19.12%-0.55
-27.81%-2.39
1.53%-0.56
Diluted earnings per share
0.00%-0.64
0.00%-0.59
-12.73%-0.62
-1.26%-2.42
-12.50%-0.63
-28.00%-0.64
16.90%-0.59
19.12%-0.55
-27.81%-2.39
1.53%-0.56
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 26.58%75.41M36.75%64.39M44.33%62.4M40.78%208.13M33.11%58.23M61.81%59.58M31.32%47.09M37.62%43.24M95.68%147.84M70.61%43.75M
Selling and administrative expenses 24.83%11.8M22.88%10.09M34.73%9.7M31.14%34.38M35.78%9.51M37.30%9.45M28.83%8.21M21.03%7.2M33.48%26.21M36.62%7M
-General and administrative expense 24.83%11.8M22.88%10.09M34.73%9.7M31.14%34.38M35.78%9.51M37.30%9.45M28.83%8.21M21.03%7.2M33.48%26.21M36.62%7M
Research and development costs 26.91%63.61M39.68%54.29M46.25%52.71M42.86%173.76M32.60%48.72M67.45%50.13M31.86%38.87M41.49%36.04M117.53%121.63M79.11%36.74M
Operating profit -26.58%-75.41M-36.75%-64.39M-44.33%-62.4M-40.78%-208.13M-33.11%-58.23M-61.81%-59.58M-31.32%-47.09M-37.62%-43.24M-95.68%-147.84M-70.61%-43.75M
Net non-operating interest income expense 13.84%4.78M96.75%5.39M78.88%4.06M227.83%13.08M83.41%3.87M179.87%4.2M907.72%2.74M2,019.63%2.27M754.18%3.99M1,871.96%2.11M
Non-operating interest income 13.84%4.78M96.75%5.39M78.88%4.06M227.83%13.08M83.41%3.87M179.87%4.2M907.72%2.74M2,019.63%2.27M754.18%3.99M1,871.96%2.11M
Other net income (expense) 1K-83.58%44K-100.04%-1K-26.77%2.64M-100.35%-7K-59.15%268K251.85%2.38M28.39%3.61M224.80%2.02M
Other non- operating income (expenses) --1K-83.58%44K-100.04%-1K-26.77%2.64M-100.35%-7K-----59.15%268K251.85%2.38M28.39%3.61M224.80%2.02M
Income before tax -27.54%-70.63M-33.75%-58.95M-51.21%-58.35M-37.20%-192.41M-37.22%-54.37M-57.95%-55.38M-26.19%-44.08M-25.96%-38.59M-94.04%-140.24M-59.03%-39.62M
Income tax
Net income -27.54%-70.63M-33.75%-58.95M-51.21%-58.35M-37.20%-192.41M-37.22%-54.37M-57.95%-55.38M-26.19%-44.08M-25.96%-38.59M-94.04%-140.24M-59.03%-39.62M
Net income continuous Operations -27.54%-70.63M-33.75%-58.95M-51.21%-58.35M-37.20%-192.41M-37.22%-54.37M-57.95%-55.38M-26.19%-44.08M-25.96%-38.59M-94.04%-140.24M-59.03%-39.62M
Minority interest income
Net income attributable to the parent company -27.54%-70.63M-33.75%-58.95M-51.21%-58.35M-37.20%-192.41M-37.22%-54.37M-57.95%-55.38M-26.19%-44.08M-25.96%-38.59M-94.04%-140.24M-59.03%-39.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -27.54%-70.63M-33.75%-58.95M-51.21%-58.35M-37.20%-192.41M-37.22%-54.37M-57.95%-55.38M-26.19%-44.08M-25.96%-38.59M-94.04%-140.24M-59.03%-39.62M
Basic earnings per share 0.00%-0.640.00%-0.59-12.73%-0.62-1.26%-2.42-12.50%-0.63-28.00%-0.6416.90%-0.5919.12%-0.55-27.81%-2.391.53%-0.56
Diluted earnings per share 0.00%-0.640.00%-0.59-12.73%-0.62-1.26%-2.42-12.50%-0.63-28.00%-0.6416.90%-0.5919.12%-0.55-27.81%-2.391.53%-0.56
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List